Andrea Galbiati is giving a presentation about Philochem’s FAP-targeted small molecule therapeutics on March 5 (main session), entitled “Detailing Clinical Development of OncoFAP: a Small Molecule Conjugate Targeting Fibroblast Activation Protein in Solid Tumours”.